ADVIA CENTAUR XPT AFP ASSAY N/A 10309979

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-06-02 for ADVIA CENTAUR XPT AFP ASSAY N/A 10309979 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[76519148] A siemens customer service engineer (cse) was sent to the customer's site for instrument inspection. Controls were tested in 10 replicates to check precision, and did not indicate a precision issue. There were no issues observed in the event log. The cse replaced the degasser, capsule filter, aspiration guide, pinch tubing, and adjusted the incubation ring and probes. The cse checked the b/f line, and fluid lines, and decontamination performed. The customer uses terumo blood (9 ml) collection tubes, and does not know how long the sample was allowed to clot before centrifugation. The terumo blood collection tube has a clot activator but does not have gel separator. The sample was centrifuged at 3,500 revolutions per minute (rpm) for 10 minutes. The cause for the discordant afp result is unknown. The non-reproduced elevated afp result may be attributed to insufficient clotting time and/or centrifugation. Siemens has recommended the customer allow samples to clot for at least 30 minutes before centrifugation, and centrifuge samples at 1000 x gravitational force (g) for 15-20 minutes. The instruction for use (ifu) states in the preparing the samples section: "before placing samples on the system, ensure that samples have the following characteristics:? Samples are free of fibrin or other particulate matter. Remove particulates by centrifugation at 1000 x g for 15-20 minutes. ? Samples are free of bubbles. " the instruction for use (ifu) under the interpretation of results section states the following: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings. " the instrument is performing within specification. No further evaluation of the device is required.
Patient Sequence No: 1, Text Type: N, H10


[76519149] A falsely elevated advia centaur xpt alpha-fetoprotein (afp) result was observed on a patient sample. The patient sample was repeated on two other advia centaur systems and the results were lower. The lower result was reported to the provider. Patient treatment was not prescribed or altered. There was no report of adverse health consequences due to the discordant advia centaur xpt result.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219913-2017-00138
MDR Report Key6607831
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-06-02
Date of Report2017-06-02
Date of Event2017-05-10
Date Mfgr Received2017-05-10
Device Manufacturer Date2016-07-27
Date Added to Maude2017-06-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSTEPHEN PERRY
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604163
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Remedial ActionIN
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XPT AFP ASSAY
Generic NameKIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS
Product CodeLOK
Date Received2017-06-02
Model NumberN/A
Catalog Number10309979
Lot Number041182
Device Expiration Date2017-10-27
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 105915097 US 105915097


Patients

Patient NumberTreatmentOutcomeDate
10 2017-06-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.